Literature DB >> 187556

Replicating DNA of herpes simplex virus type 1.

I Hirsch, J Roubal, V Vonka.   

Abstract

Newly synthesized herpes simplex virus type 1 DNA yielded a heterogeneous sedimentation profile in neutral sucrose gradients, with the main peak occurring at approximately 40S. Components sedimenting slower than virion DNA and a rapidly sedimenting intracellular HSV DNA were also observed. Both the low-molecular weight and the rapidly sedimenting components seemed to be precursors of virion DNA: they almost completely disappeared after a 60-min chase of a 3-min pulse of 3H-thymidine, and were converted into DNA which cosedimented with virion 32P-labeled DNA. However, sedimentation analysis in alkaline sucrose gradients showed that a 60-min period was insufficient for completing the maturation of HSV DNA. Cleavage of parental DNA molecules was observed in neutral sucrose gradients after infection with 3H-thymidine-labeled virions. No evidence for the formation of covalently closed circles during the replication process was obtained. The presence of single-stranded regions in the replicative form of HSV DNA was revealed. Some of the short-pulse (30 sec) labeled HSV DNA (26.1%) was eluted from hydroxylapatite columns with the properties of single-stranded DNA, and 22% of its trichloroacetic acid precipitability was susceptible to single-strand specific S1 nuclease treatment. Pulse-chase experiments indicated that the life-time of this single-stranded component in nascent DNA was probably not longer than 3 min. A small proportion of single-stranded regions, however, survived for longer periods. Almost all of the newly synthesized short-pulse-labeled HSV DNA exhibited an affinity for nitrocellulose filters. This affinity, which was S1 nuclease-sensitive, gradually decreased with prolongation of the time of the chase. After chasing the pulse for 1 h, the attachment of newly synthesized DNA was comparable with virion DNA.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 187556     DOI: 10.1159/000149949

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  8 in total

1.  Anatomy of herpes simplex virus DNA. XII. Accumulation of head-to-tail concatemers in nuclei of infected cells and their role in the generation of the four isomeric arrangements of viral DNA.

Authors:  R J Jacob; L S Morse; B Roizman
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

2.  Focus formation and neoplastic transformation by herpes simplex virus type 2 inactivated intracellularly by 5-bromo-2'-deoxyuridine and near UV light.

Authors:  M M Manak; L Aurelian; P O Ts'o
Journal:  J Virol       Date:  1981-10       Impact factor: 5.103

3.  Structure of replicating herpes simplex virus DNA.

Authors:  C V Jongeneel; S L Bachenheimer
Journal:  J Virol       Date:  1981-08       Impact factor: 5.103

4.  Replication of herpes simplex virus type I DNA in permeabilized infected cells.

Authors:  C V Jongeneel; S L Bachenheimer
Journal:  Nucleic Acids Res       Date:  1980-04-11       Impact factor: 16.971

5.  Initiation of lytic DNA replication in Epstein-Barr virus: search for a common family mechanism.

Authors:  Andrew J Rennekamp; Paul M Lieberman
Journal:  Future Virol       Date:  2010-01       Impact factor: 1.831

6.  Structure of the herpes simplex virus 1 genome: manipulation of nicks and gaps can abrogate infectivity and alter the cellular DNA damage response.

Authors:  Samantha Smith; Nina Reuven; Kareem N Mohni; April J Schumacher; Sandra K Weller
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

7.  Human cytomegalovirus DNA replicates after early circularization by concatemer formation, and inversion occurs within the concatemer.

Authors:  M A McVoy; S P Adler
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

8.  In vitro processing of herpes simplex virus type 1 DNA replication intermediates by the viral alkaline nuclease, UL12.

Authors:  J N Goldstein; S K Weller
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.